Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
medical emergency |
| gptkbp:affects |
gptkb:skin
mucous membranes |
| gptkbp:ageGroupAffected |
all ages
|
| gptkbp:alsoKnownAs |
gptkb:SJS
|
| gptkbp:cause |
unknown
infection adverse drug reaction |
| gptkbp:commonDrugsCausing |
gptkb:NSAIDs
antibiotics allopurinol anticonvulsants |
| gptkbp:commonIn |
adults
males |
| gptkbp:complication |
gptkb:pneumonia
sepsis vision loss organ failure permanent skin damage |
| gptkbp:diagnosedBy |
clinical evaluation
skin biopsy |
| gptkbp:field |
immunology
internal medicine dermatology |
| gptkbp:firstDescribed |
1922
|
| https://www.w3.org/2000/01/rdf-schema#label |
Stevens-Johnson syndrome
|
| gptkbp:ICD-10_code |
L51.1
|
| gptkbp:mortalityRate |
5-10%
|
| gptkbp:namedAfter |
gptkb:Albert_Mason_Stevens
gptkb:Frank_Chambliss_Johnson |
| gptkbp:relatedTo |
gptkb:toxic_epidermal_necrolysis
|
| gptkbp:riskFactor |
immunosuppression
HIV infection genetic predisposition |
| gptkbp:symptom |
fever
fatigue sore throat blisters painful red or purplish rash skin peeling |
| gptkbp:treatment |
supportive care
pain management wound care hospitalization IV fluids antibiotics (if infection present) discontinuation of causative drug |
| gptkbp:bfsParent |
gptkb:SJS
gptkb:phenytoin gptkb:fluconazole gptkb:Sulfanilamide gptkb:carbamazepine gptkb:Sulfonamides |
| gptkbp:bfsLayer |
6
|